Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.89B |
| 2 |
Tesla
TSLA
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$1.77B |
| 4 |
VICI Properties
VICI
|
+$1.23B |
| 5 |
Amazon
AMZN
|
+$1.22B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.57B |
| 2 |
CERN
Cerner Corp
CERN
|
+$3.01B |
| 3 |
Occidental Petroleum
OXY
|
+$1.31B |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.05B |
| 5 |
PBCT
People's United Financial Inc
PBCT
|
+$961M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.63% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AWH
3926
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $1.54M | ﹤0.01% |
174,343
-30,183
| -15% | -$306K |
|
3927
Avalo Therapeutics
AVTX
$983M
| $1.53M | ﹤0.01% |
1,066
-109
| -9% | -$146K |
|
|
SRT
3928
DELISTED
Startek Inc.
SRT
| $1.53M | ﹤0.01% |
528,377
-70,821
| -12% | -$262K |
|
|
AGTC
3929
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.53M | ﹤0.01% |
1,981,565
| – | – |
|
3930
United States Antimony
UAMY
$1.02B
| $1.52M | ﹤0.01% |
3,774,437
-73,338
| -2% | -$31.8K |
|
3931
PagSeguro Digital
PAGS
$2.55B
| $1.52M | ﹤0.01% |
148,484
+2,337
| +2% | +$33.5K |
|
|
FTH
3932
Faeth Therapeutics
FTH
$629M
| $1.52M | ﹤0.01% |
33,479
-4,319
| -11% | -$162K |
|
3933
Transact Technologies
TACT
$58.6M
| $1.52M | ﹤0.01% |
381,371
| – | – |
|
|
ATXS
3934
DELISTED
Astria Therapeutics
ATXS
| $1.51M | ﹤0.01% |
503,410
-29,158
| -5% | -$131K |
|
3935
CPS Technologies
CPSH
$86.1M
| $1.51M | ﹤0.01% |
490,651
| – | – |
|
|
USWS
3936
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
| $1.51M | ﹤0.01% |
267,245
+205,484
| +333% | +$1.03M |
|
|
PW
3937
Power REIT
PW
$2.84M
| $1.5M | ﹤0.01% |
11,788
-102
| -0.9% | -$24.7K |
|
|
RIBT
3938
DELISTED
RiceBran Technologies
RIBT
| $1.5M | ﹤0.01% |
224,042
+95,011
| +74% | +$580K |
|
3939
Smart Sand
SND
$194M
| $1.49M | ﹤0.01% |
746,561
-212,361
| -22% | -$734K |
|
3940
AudioEye
AEYE
$75M
| $1.49M | ﹤0.01% |
247,820
| – | – |
|
|
DALN
3941
DELISTED
DallasNews
DALN
| $1.49M | ﹤0.01% |
235,216
| – | – |
|
3942
SurgePays
SURG
$7.27M
| $1.49M | ﹤0.01% |
308,076
+4,107
| +1% | +$17.3K |
|
3943
LiveOne
LVO
$58.2M
| $1.48M | ﹤0.01% |
173,272
-5,084
| -3% | -$41.7K |
|
3944
Enel Chile
ENIC
$6.28B
| $1.48M | ﹤0.01% |
1,335,605
| – | – |
|
|
EVFM
3945
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.47M | ﹤0.01% |
1,304,514
+876,564
| +205% | +$1.45M |
|
|
SCX
3946
DELISTED
The L.S. Starrett Company
SCX
| $1.47M | ﹤0.01% |
209,856
| – | – |
|
3947
Hyperfine
HYPR
$94.8M
| $1.47M | ﹤0.01% |
659,516
-1,102,094
| -63% | -$3.24M |
|
|
TTOO
3948
DELISTED
T2 Biosystems, Inc
TTOO
| $1.47M | ﹤0.01% |
1,818
+813
| +81% | +$1.2M |
|
3949
Soluna Holdings
SLNH
$185M
| $1.47M | ﹤0.01% |
14,403
-365
| -2% | -$71K |
|
3950
Broadway Financial
BYFC
$103M
| $1.46M | ﹤0.01% |
172,685
-62,670
| -27% | -$747K |
|
Similar funds
Vanguard Group's Q2 2022 Portfolio in Review
As of Q2 2022, Vanguard Group held 4,705 positions worth $3.56T, down 16% from $4.23T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 3.5%. Vanguard Group opened 80 new positions and exited 84, leaving the 4,705-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q2 2022 buy was ESAB: 5,042,669 shares worth $221M.
- Vanguard Group added most to Warner Bros in Q2 2022, an estimated $2.89B increase.
- Vanguard Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.57B.
- Vanguard Group fully exited Cerner Corp in Q2 2022, selling an estimated $3.01B.
- Vanguard Group's ten largest holdings make up 20% of its $3.56T portfolio in Q2 2022.
- Vanguard Group opened 80 new positions and closed 84 in Q2 2022.
- Vanguard Group's portfolio value fell 16% quarter-over-quarter to $3.56T.
Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.